Prime Medicine Cash Flow Statement (2021-2026) | PRME

Cash Flow Statement Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -16.41M-62.90M-23.84M-29.35M-29.35M-39.28M-39.40M-42.38M-50.71M-65.64M-45.76M-55.33M-52.52M-42.28M-51.89M-52.59M-52.83M-47.52M-49.63M
Share-based Compensation (Quarter) 1.11M1.12M1.34M1.42M2.57M1.68M3.58M4.22M4.43M5.21M8.09M6.83M5.94M5.68M6.33M12.75M4.51M4.64M
Deferred Taxes (Quarter) 1.24M-0.53M-0.44M0.21M-0.20M-0.20M0.03M-0.11M0.13M-0.13M
Gains from Investment Securities (Quarter) 28.57M0.02M-36.72M-1.70M4.97M-6.28M2.99M44.94M-45.48M0.06M-1.06M-0.51M85.32M-83.33M
Cash from Operations (Quarter) -13.19M-50.79M-20.22M-30.10M-30.71M-41.56M-40.82M-39.17M-43.86M-67.71M-45.49M-25.91M16.25M-48.86M-41.41M-35.04M-37.26M-42.71M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) -3.62M1.77M-2.02M0.15M9.89M0.61M5.69M3.14M3.35M3.35M4.57M2.23M2.21M2.41M2.35M2.33M2.60M2.84M
Depreciation & Amortization (CF) (Quarter) 0.20M0.26M0.29M0.43M0.63M0.87M1.05M1.12M1.24M1.25M1.31M1.54M1.56M1.72M1.70M1.86M1.88M1.88M1.86M
Change in Working Capital
Change in Receivables (Quarter) 55.00M0.02M0.10M-0.12M
Change in Account Payables (Quarter) 0.08M1.05M1.38M-0.40M0.43M-0.50M1.61M5.76M2.28M-5.88M-3.35M1.51M2.46M1.88M-3.35M3.04M-0.58M3.55M
Change in Accured Expenses (Quarter) 33.31M-33.32M2.47M0.89M4.09M-4.05M0.61M2.68M2.51M-4.47M0.54M5.93M-0.14M-6.66M4.96M-1.07M1.60M-4.50M
Investing Activities
Capital Expenditures (Quarter) -3.01M1.69M0.90M-1.71M0.10M2.60M-1.89M6.17M1.84M2.32M-1.97M-0.24M1.04M2.42M-2.27M4.09M-4.13M0.21M
Change in Acquisitions & Divestments (Quarter) 13.00M32.50M29.50M6.00M25.00M35.00M30.00M20.02M47.53M72.50M37.50M61.30M32.90M3.00M11.25M42.43M39.10M50.89M
Cash from Investing Activities (Quarter) 12.15M30.89M-50.79M-13.51M-13.69M-12.66M27.86M-37.77M41.28M-37.03M6.89M50.34M48.25M-47.74M2.77M-92.12M28.33M43.39M
Financing Activities
Other financing activities (Quarter) 1.09M1.27M0.62M0.75M1.40M
Change in Capital Stock
Shares Issued (Quarter) 0.06M185.25M0.46M-0.46M1.20M-1.13M0.03M37.98M0.78M0.39M
Misc.
Cash from Financing Activities (Quarter) -1.09M-1.27M-0.62M-0.68M184.07M0.07M0.07M0.32M0.19M157.33M0.04M38.51M0.00M6.00M0.20M144.75M0.56M0.39M
Change in Cash (Quarter) -2.12M-21.17M-71.64M-44.29M139.67M-54.16M-12.88M-76.62M-2.38M52.59M-38.56M62.94M64.50M-90.60M-38.44M17.59M-8.36M1.07M
Free Cash Flow (Quarter) -10.17M-52.48M-21.12M-28.39M-30.81M-44.16M-38.93M-45.34M-45.70M-70.03M-43.52M-25.67M15.20M-51.28M-39.14M-39.13M-33.13M-42.92M
Net Cash Flow (Quarter) -2.12M-21.17M-71.64M-44.29M139.67M-54.16M-12.88M-76.62M-2.38M52.59M-38.56M62.94M64.50M-90.60M-38.44M17.59M-8.36M1.07M